Literature DB >> 15982989

Diazepam suppresses the acquisition but not the expression of 'fear-potentiation' of the acoustic startle response in man.

J C Scaife1, R W Langley, C M Bradshaw, E Szabadi.   

Abstract

Sudden auditory stimuli elicit a short-latency muscular response (acoustic startle response) which is enhanced during presentation of a Pavlovian conditioned stimulus (CS) that has previously been paired with an aversive unconditioned stimulus (US) ('fear-potentiation'). In rodents, acute treatment with benzodiazepines blocks both the acquisition of fear-potentiation and the expression of fear-potentiation induced by prior exposure to CS/US pairing. We examined the effect of diazepam on the acquisition and expression of fear-potentiation of the acoustic startle response in man. Forty-six male volunteers (18-30 years) participated in two sessions separated by 7 days. In session 1, they were exposed to 20 2-s presentations of a light (CS), 50% of which terminated with an electric shock to the wrist (1.8 mA, 50 ms: US). Somatosensory potentials evoked by the US were recorded from the scalp at Cz, and skin conductance responses from electrodes taped to the second and fourth fingers. In session 2, the CS was presented 20 times without the US; a random 50% of CS presentations terminated with a sound pulse (40-ms 115-dB 1-kHz); an equal number of sound pulses was presented without the CS. Electromyographic responses of the orbicularis oculi muscle to the acoustic stimuli were recorded from electrodes placed on the lower eyelid, late-latency auditory evoked potentials were recorded at Cz, and skin conductance responses from electrodes taped to the second and fourth fingers. In each session, alertness was measured using visual analogue self-rating scales and critical flicker fusion frequency. Subjects received placebo or diazepam 10mg in the two sessions in a double-blind protocol: group 1 (n 12) placebo/placebo; group 2 (n 11) placebo/diazepam; group 3 (n 12) diazepam/placebo; group 4 (n 11) diazepam/diazepam. Diazepam reduced alertness as measured by visual-analogue self-rating scales and critical flicker fusion frequency. In session 1, diazepam reduced the amplitude of the somatosensory potentials and skin conductance responses evoked by the CS. In session 2, the acoustic startle response, the N1/P2 auditory evoked response and the skin conductance response evoked by the sound stimuli were enhanced in the presence of the CS. This fear-potentiation was attenuated in subjects who received diazepam in session 1, but was not affected by the treatment given in session 2. The results indicate that diazepam blocks the acquisition of fear-potentiation of startle responses in man, as in animals, but does not prevent the expression of a previously learned response.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15982989     DOI: 10.1177/0269881105053285

Source DB:  PubMed          Journal:  J Psychopharmacol        ISSN: 0269-8811            Impact factor:   4.153


  15 in total

1.  Drugs, sweat, and fears: a comparison of the effects of diazepam and methylphenidate on fear conditioning.

Authors:  Catherine M Brignell; H Valerie Curran
Journal:  Psychopharmacology (Berl)       Date:  2006-05-03       Impact factor: 4.530

2.  Emotion regulation and potentiated startle across affective picture and threat-of-shock paradigms.

Authors:  Shmuel Lissek; Kaebah Orme; Dana J McDowell; Linda L Johnson; David A Luckenbaugh; Johanna M Baas; Brian R Cornwell; Christian Grillon
Journal:  Biol Psychol       Date:  2007-07-13       Impact factor: 3.251

3.  The CRH1 antagonist GSK561679 increases human fear but not anxiety as assessed by startle.

Authors:  Christian Grillon; Elizabeth Hale; Lynne Lieberman; Andrew Davis; Daniel S Pine; Monique Ernst
Journal:  Neuropsychopharmacology       Date:  2015-03-13       Impact factor: 7.853

4.  Phasic and sustained fear are pharmacologically dissociable in rats.

Authors:  Leigh Miles; Michael Davis; David Walker
Journal:  Neuropsychopharmacology       Date:  2011-04-06       Impact factor: 7.853

5.  Selective effects of benzodiazepines on the acquisition of conditioned taste aversion compared to attenuation of neophobia in C57BL/6 mice.

Authors:  Zsuzsanna Callaerts-Vegh; Daniel Hoyer; Peter H Kelly
Journal:  Psychopharmacology (Berl)       Date:  2009-07-22       Impact factor: 4.530

Review 6.  Phasic vs sustained fear in rats and humans: role of the extended amygdala in fear vs anxiety.

Authors:  Michael Davis; David L Walker; Leigh Miles; Christian Grillon
Journal:  Neuropsychopharmacology       Date:  2010-01       Impact factor: 7.853

7.  Arousal and the pupil: why diazepam-induced sedation is not accompanied by miosis.

Authors:  R H Hou; E R Samuels; R W Langley; E Szabadi; C M Bradshaw
Journal:  Psychopharmacology (Berl)       Date:  2007-07-22       Impact factor: 4.530

Review 8.  Metabotropic glutamate receptor modulation, translational methods, and biomarkers: relationships with anxiety.

Authors:  R E Nordquist; T Steckler; J G Wettstein; C Mackie; W Spooren
Journal:  Psychopharmacology (Berl)       Date:  2008-03-06       Impact factor: 4.530

Review 9.  Assessing anxiety in nonhuman primates.

Authors:  Kristine Coleman; Peter J Pierre
Journal:  ILAR J       Date:  2014

10.  Validating a human model for anxiety using startle potentiated by cue and context: the effects of alprazolam, pregabalin, and diphenhydramine.

Authors:  J M P Baas; N Mol; J L Kenemans; E P Prinssen; I Niklson; C Xia-Chen; F Broeyer; J van Gerven
Journal:  Psychopharmacology (Berl)       Date:  2009-05-05       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.